US 12,759,978 B2Granted

Psilocin analog compositions and methods of synthesizing the same

AssigneeMydecine Innovations Group Inc.

InventorsDenton W. Hoyer, Robert F. Roscow

Life of this patent

Estimating the term…

Abstract

The present invention is directed to novel chemical compositions of matter and their methods of synthesis, and in particular novel analogs of Psilocin having enhanced physical and pharmacokinetic characteristics.

Claims2

Dependent claims

A psilocin analog according to Formula VIII:

or pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 18/141,844Filed 1 May 2023 · continuation in part
Priority: 3 Dec 2020
Published: US 2023/0271924 A131 Aug 2023
Granted: 13 Oct 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

C07D 209/14
With substituted hydrocarbon radicals attached to carbon atoms of the hetero ring: radicals substituted by nitrogen atoms, not forming part of a…
C07D 209/12
With substituted hydrocarbon radicals attached to carbon atoms of the hetero ring: radicals substituted by oxygen atoms
C07D 209/16
Radicals substituted by nitrogen atoms, not forming part of a nitro radical: tryptamines
C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems

Family

Application63/121,052Us provisional application · filed 3 Dec 2020
PCT/US2021/061826Parent of this continuation-in-part · filed 3 Dec 2021
US 2023/0271924 A1Pre-grant publication · published 31 Aug 2023
US 12,759,978 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results